Table 1 Patient characteristics
Variables | Category | Group A (TTE) | Group B (THE) | P value |
|---|---|---|---|---|
n (%) 47, (54.02%) | n (%) 40, (45.97%) | |||
Age (Mean ± SD) | Year | 65.60 ± 6.30 | 63.48 ± 9/34 | 0.212 |
Age group | 40–50 | 1 (2.1%) | 5 (12.5%) | |
51–60 | 9 (19.1%) | 7 (17.5%) | ||
61–70 | 29 (61.7%) | 24 (60%) | ||
71–80 | 8 (17%) | 4 (10%) | ||
Gender | Male | 30 (63.8%) | 27 (67.5%) | 0.720 |
Female | 17 (36.2%) | 13 (32.5%) | ||
Smoking | 26 (55.3%) | 24 (60%) | 0.660 | |
Comorbidities | DM | 19 (40.4%) | 11 (27.5%) | 0.206 |
HTN | 41 (87.2%) | 31 (77.5%) | 0.231 | |
IHD | 25 (53.2%) | 27 (67.5%) | 0.175 | |
COAD | 8 (17%) | 14 (35%) | 0.055+ | |
Clinical stages | I | 3 (6.4%) | 1 (2.5%) | 0.489 |
II | 20 (42.5%) | 13 (32.5%) | ||
III | 24 (51.0%) | 26 (65.0%) | ||
Histology | SCC | 35 (74.4%) | 24 (60%) | 0.529 |
Adenocarcinoma | 12 (25.5%) | 16 (40%) |